Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-09-12EMA Authorised: Velsipity (Etrasimod arginine) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Velsipity (etrasimod arginine) by Pfizer Europe MA EEIG for the treatment of ulcerative colitis.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis [Phase 2, Phase 3]
This clinical trial update outlines long-term efficacy and safety investigations of fecal microbiota transplantation for ulcerative colitis,…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
A clinical trial evaluating the role of bile acids and gut microbiota in Clostridioides difficile infection among patients with ulcerative c…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]
This is a completed special drug-use surveillance study of 300 mg intravenous vedolizumab for ulcerative colitis, with results posted on 202…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD [NA]
The clinical trial evaluating a fasting-mimicking diet for depressive symptoms in inflammatory bowel disease has completed. The study includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
The document reports a clinical trial investigating a multimodal day hospital approach for managing chronic inflammatory bowel diseases, inc…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis [Phase 2]
Phase 2 study evaluating amiselimod (MT-1303) for mild to moderate ulcerative colitis has completed. The update does not provide efficacy or…
-
EMA withdrawal · 2025-09-08EMA Withdrawn: Eksunbi (ustekinumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn Eksunbi (ustekinumab) from the European market as of 23 May 2025, affecting indications for Crohn's disease, ulcerativ…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Multiple Digital Biomarkers for Optimization of IBD Care
A clinical trial is evaluating multiple digital biomarkers to optimize care for inflammatory bowel disease, including Crohn's disease and ul…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 update reporting long-term safety and efficacy data for ABX464 in adults with moderate-to-severe active ulcerative colitis; the stud…
-
FDA approval · 2025-09-03FDA Approved: INFLECTRA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Inflectra (infliximab-dyyb) from Pfizer to update its labeling and/or indications, following…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
A real-world study in Poland evaluating Vedolizumab for adults with ulcerative colitis or Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study [NA]
An open-label randomized controlled study evaluating the efficacy and mechanism of fecal microbiota transplantation for inflammatory bowel d…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Rutin Therapy Role in Reducing Ulcerative Colitis Severity [NA]
A completed clinical trial from Benha University evaluated rutin therapy for reducing the severity of ulcerative colitis.
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer
A clinical trial is recruiting to test an ingestible 'smart pill' that measures gut health in ulcerative colitis and colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis [Phase 2]
Phase 2 study of SPH3127 for mild to moderate ulcerative colitis has completed. This update confirms the Phase 2 trial status but does not p…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis [NA]
A clinical trial update describes an evaluation of vedolizumab combined with upadacitinib for ulcerative colitis, with study status currentl…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: SMART-IBD App Trial [NA]
ClinicalTrials.gov shows the SMART-IBD app trial for inflammatory bowel disease has completed; the sponsor is Children’s Hospital Medical Ce…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology [NA]
Clinical trial exploring tissue repair in inflammatory bowel disease using organoid technology. Recruitment is ongoing for Crohn's disease, …
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis [Phase 1]
Phase 1 clinical trial update reports termination of a study evaluating the effect of ustekinumab on cytochrome P450 enzyme activities in ad…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Improving the Quality of Care for Adults With Inflammatory Bowel Disease
A clinical trial sponsored by Dartmouth-Hitchcock Medical Center aims to improve the quality of care for adults with inflammatory bowel dise…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Molecular Inflammation Board at the Center for Personalized Medicine
A University Hospital Tuebingen clinical trial is recruiting for a personalized medicine program targeting psoriasis, psoriatic arthritis, i…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis [NA]
A completed clinical trial evaluated how circadian misalignment affects colonic barrier homeostasis in ulcerative colitis, with the results …
-
FDA approval · 2025-08-14FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for OTULFI (ustekinumab-AAUZ) from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-08-13FDA Approved: MESALAMINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic mesalamine product after Camber Pharmaceuticals' Original Application (ANDA 219864).